ArticleOncotarget2014

CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.

Lei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.